Medications

Sanofi buys US flu vaccine maker Protein for $750 mln

French pharmaceuticals giant Sanofi, which is looking to boost its presence in biotechnology, said Tuesday it had agreed to buy the privately-owned US vaccines maker Protein Sciences for up to $750 million (658 million euros).

Diseases, Conditions, Syndromes

First dengue vaccine goes on sale in Guatemala

The world's first vaccine against dengue, a mosquito-borne virus that causes fever and pain and can be fatal, will go on sale in Guatemala within weeks, the French company making it said Tuesday.

Diseases, Conditions, Syndromes

France's Sanofi to work with US Army on Zika vaccine

French pharmaceuticals group Sanofi said Wednesday it would work with the US Army's Walter Reed Institute to develop a potential vaccine against the mosquito-borne Zika virus, linked to brain damage in newborns.

Diseases, Conditions, Syndromes

UGA, Sanofi Pasteur develop new vaccine for H1N1 influenza

Researchers at the University of Georgia and Sanofi Pasteur, the vaccines division of Sanofi, announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza ...

Diseases, Conditions, Syndromes

Brazil authorizes dengue vaccine

Brazil became the first South American country Monday to authorize the world's first-ever dengue fever vaccine, which its French manufacturer says has the potential to save hundreds of lives here.

Medications

Doctors Without Borders: snakebite treatment running out

Doctors Without Borders says the world will run out of one of the most effective treatments for snakebites next year, putting the lives of tens of thousands of people at risk, mostly in developing countries.

Diseases, Conditions, Syndromes

Dengue vaccine to be tested in India

French health care giant Sanofi Pasteur will soon test a vaccine against dengue fever in India amid concerns about the increasingly global spread of the disease, reports said Monday.

page 2 from 4